Zhang Jun, Dong Meng-Jie, Yang Jun, Tian Dan
Department of Nuclear Medicine, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Medicine (Baltimore). 2019 Jun;98(24):e16077. doi: 10.1097/MD.0000000000016077.
Secondary hyperparathyroidism (SHPT) is often complicated with chronic renal failure. Though the total parathyroidectomy (TPTX) with forearm autotransplantation (FAT) has been commonly used to treatment refractory renal SHPT, the recurrence of SHPT is not infrequent, resulting from hyperplastic autograft, remnant parathyroid tissues, and supernumerary parathyroid gland (SPG).
A 67-year-old man undergoing TPTX+FAT 4 years previously for renal SHPT, who received regular hemodialysis with active vitamin D supplements of Rocaltrol treatment postoperatively, was admitted to our hospital with progressively elevated serum intact parathyroid hormone (iPTH) from 176 to 1266 pg/mL for 8 months and bilateral ankle joints pain for 1 month. Tc-sestamibi dual-phase imaging with single positron emission tomography (SPECT)/computed tomography (CT) revealed a nodule in suprasternal fossa, besides a nodule in autografted site, accompanied with intense radioactivity.
Recurrent SHPT was easily diagnosed based on previous medical history, painful joints, increased serum iPTH level and positive findings of Tc-sestamibi imaging. Routine postoperative pathology showed that the nodules were consistent with an adenomatoid hyperplasic autograft and a supernumerary parathyroid adenoma in suprasternal fossa, respectively.
Reoperation for removing nodules in suprasternal fossa and autografted site was performed 1 month later. Then regular hemodialysis 3 times a week with Rocaltrol was continued.
During 12 months of follow-up, the joints pain improved obviously and the serum iPTH level ranged from 30.1 to 442 pg/mL.
Although rare, recurrent renal SHPT may be caused by a coexistence of both hyperfunctional autograft and SPG after TPTX+FAT. The Tc-sestamibi parathyroid imaging with SPECT/CT is helpful to locate the culprits of recurrent renal SHPT before reoperation. To prevent recurrence of renal SHPT, the present initial surgical procedures should be further optimized in patient on permanent hemodialysis.
继发性甲状旁腺功能亢进症(SHPT)常与慢性肾衰竭并发。尽管甲状旁腺全切术(TPTX)联合前臂自体移植术(FAT)已普遍用于治疗难治性肾性SHPT,但SHPT复发并不罕见,其原因包括自体移植增生、甲状旁腺残余组织和甲状旁腺增生(SPG)。
一名67岁男性,4年前因肾性SHPT接受TPTX+FAT手术,术后接受规律血液透析并补充活性维生素D罗钙全治疗,因血清完整甲状旁腺激素(iPTH)在8个月内从176 pg/mL逐渐升高至1266 pg/mL以及双侧踝关节疼痛1个月入院。锝- sestamibi双期显像结合单光子发射计算机断层扫描(SPECT)/计算机断层扫描(CT)显示,除自体移植部位有一个结节外,胸骨上窝还有一个结节,伴有强烈放射性。
根据既往病史、关节疼痛、血清iPTH水平升高以及锝- sestamibi显像阳性结果,复发性SHPT很容易诊断。术后常规病理显示,结节分别与自体移植腺瘤样增生和胸骨上窝甲状旁腺增生腺瘤一致。
1个月后再次手术切除胸骨上窝和自体移植部位的结节。然后继续每周进行3次规律血液透析并使用罗钙全。
在12个月的随访期间,关节疼痛明显改善,血清iPTH水平在30.1至442 pg/mL之间。
尽管罕见,但复发性肾性SHPT可能是由于TPTX+FAT术后高功能自体移植和SPG并存所致。锝- sestamibi甲状旁腺显像结合SPECT/CT有助于在再次手术前定位复发性肾性SHPT的病因。为防止肾性SHPT复发,目前的初始手术方法应在长期血液透析患者中进一步优化。